We examined the utility of a PCR-based method termed cleaved amplified polymorphic sequences (CAPS) to type 35 well-characterized isolates of Staphylococcus epidermidis. The results were compared with detailed epidemiologic information and typing obtained by using pulsed-field gel electrophoresis (PFGE). To identify CAPS markers for this study, eight pairs of oligonucleotide primers corresponding to five previously sequenced S. epidermidis genes were synthesized and then used to amplify DNA sequences from the S. epidermidis strains by using PCR. Amplified products were reproducibly obtained for seven of eight primer pairs from chromosomal DNA of 33 of the 35 isolates. Seven restriction site polymorphisms were found in five of the amplified products when they were subjected to digestion with a panel of restriction endonucleases. Each fragmentenzyme combination that was polymorphic demonstrated only two alleles in the 33 S. epidermidis isolates analyzed, corresponding to the presence or absence of a single restriction site. Overall, five distinct combinations of alleles were detected and were designated CAPS types A through E. There was a close correlation between the CAPS grouping, the epidemiologic information for the strains, and grouping by PFGE following SmaI digestion of chromosomal DNA. Although PFGE analysis was more discriminatory than typing based on the limited number of CAPS markers used in this study (isolates from the same CAPS group were sometimes distributed into more than one PFGE group), no isolates from the same PFGE group were found in more than one CAPS group. The CAPS procedure was highly reproducible, in contrast to published experience with arbitrarily primed PCR. These preliminary data suggest that CAPS represents a PCR-based technique for strain typing that is highly reproducible, rapid, utilizes widely available technologies, and provides results that are relatively easy to interpret and express.
The ability to analyze multiple bacterial isolates of a particular species to determine whether they represent the same strain is increasingly recognized as being of major importance in clinical microbiology (1) . Comparison of isolates from different patients is important in determining whether the isolates are epidemiologically linked as part of an outbreak; such information is vital to infection control efforts. Comparison of different isolates from a single patient is important in establishing whether multiple isolates represent a single infecting strain. The clinician can compare isolates from different sites in the same patient to determine whether one is the source of the other or can compare different isolates from the same site over time, which may provide evidence of persistent infection (as in endocarditis) or of relapse following therapy.
A variety of phenotypic and genotypic methods have been used to identify strains within individual bacterial species (1) . The subject of this article concerns strain typing of Staphylococcus epidermidis. In 1994, Tenover et al. (10) compared 12 existing methods for typing isolates of Staphylococcus aureus. The authors concluded that genotypic techniques, particularly pulsed-field gel electrophoresis (PFGE), were the most effective in correctly grouping outbreak strains. Methods for identifying strains of coagulase-negative staphylococci have been less thoroughly examined. These organisms are important nosocomial pathogens and the principal cause of infections associated with indwelling and prosthetic devices. In 1985, Mickelsen et al. (9) studied an outbreak of prosthetic valve endocarditis caused by S. epidermidis, utilizing plasmid profiles, phage typing, antibiograms, and biotyping. They showed that plasmid profiles and antibiograms were unstable and could not reliably evaluate the relatedness of isolates of S. epidermidis that represented a single strain as defined by epidemiology and by phage typing. In 1990, Boyce et al. (2) traced an outbreak of S. epidermidis infection in patients undergoing cardiac surgery to a common source, related to the carriage of the outbreak strain on the hands of an individual cardiac surgeon. Organisms belonging to this restricted outbreak were successfully typed by using antibiogram, biotyping, plasmid profiles, and EcoRI restriction endonuclease digestion profiles of purified plasmid DNA. In 1994, Huebner et al. (6) used PFGE of SmaI digests of chromosomal DNA to identify strains of coagulasenegative staphylococci that caused bloodstream infection in neonates in an intensive care unit. At the present time, PFGE is the most commonly used method for analyzing isolates of coagulase-negative staphylococci in the investigation of outbreaks.
In this report, we describe the adaptation of a simple PCRbased method called CAPS (cleaved amplified polymorphic sequences) for the typing of isolates of S. epidermidis. The CAPS method has been previously used to detect polymorphic restriction enzyme recognition sites in plants (7, 12, 14, 15) . CAPS utilizes DNA fragments amplified by PCR, which are then digested with a restriction endonuclease to display a poly-morphic restriction site. We have adapted the CAPS procedure to bacterial strain typing and report here results for 33 well-characterized isolates of coagulase-negative staphylococci compared with primary epidemiologic information for these isolates and with PFGE typing.
Isolates. Detailed information about isolates of S. epidermidis used in this study is shown in Table 1 . The speciation of all of these isolates as S. epidermidis was confirmed in the Clinical Microbiology Laboratory at the Massachusetts General Hospital by using the API Staph system (bioMerieux, Hazelwood, Mo.). Stocks of each isolate were derived from a single colony and stored at Ϫ70ЊC in Luria-Bertani medium containing 15% glycerol. Fresh plates were prepared from these stocks as necessary for use with the different typing procedures. Restriction endonucleases were from New England Biolabs (Beverly, Mass.), and Taq polymerase was from Fisher Scientific (Pittsburgh, Pa.). Oligonucleotides were synthesized at an institutional core facility, with the Expedite Nucleic Acid Synthesis system, model 8909 (Millipore Corp., Bedford, Mass.).
Amplification of S. epidermidis DNA by using CAPS primers and identification of polymorphic restriction sites. To facilitate the development of a set of CAPS markers that could be used to distinguish the S. epidermidis isolates, we first identified a set of S. epidermidis genes that had already been sequenced and then used these sequenced genes to design PCR primers. As shown in Table 2 , we used this DNA sequence information to design pairs of synthetic oligonucleotides that could be used as primers in PCR to amplify regions ranging in size from 641 to 1,150 bp.
Chromosomal DNA from each bacterial isolate was prepared for PCR by scooping up one loopful of colonies off a fresh plate, mixing the bacteria with 200 l of distilled water, boiling for 5 min, centrifuging in an Eppendorf centrifuge at 16,000 ϫ g for 5 min, and recovering the supernatant. Ten microliters of supernatant was used in each 100-l PCR, along with 25 mol of each oligonucleotide primer and 2.5 U of Taq polymerase. PCR conditions were 95ЊC for 5 min, followed by 30 cycles at 95ЊC for 1 min, annealing for 1 min at the temperature shown in Table 2 , and extension at 72ЊC for 1 min. Following 30 cycles, the reaction was completed with extension at 72ЊC for 5 additional min. Each PCR product was precipitated with ammonium acetate and ethanol and resuspended in 100 l of buffer (10 mM Tris, 1 mM EDTA [pH 8.0]).
We were unsuccessful in reproducibly amplifying fragment 7 from the sequence of lantibiotic (pepA) and immunity protein (pepI), GenBank accession number L23967, using a variety of primer pairs, and this reaction was not used in subsequent testing. For reasons that are uncertain, two isolates of S. epidermidis from patients with prosthetic valve endocarditis (not shown in Table 1 ) did not give reproducible PCR amplification products with some of the primer pairs in Table 2 and were not included in the results.
For each primer pair shown in Table 2 , we derived PCRamplified products from each of the 33 isolates. PCR products were combined in groups of five, with 3 l of product from each of five isolates in total volumes of 20 l, and digested with each of the 70 restriction endonucleases available from New England Biolabs. For each restriction enzyme, the digestion products from each group of five isolates were electrophoresed in adjacent lanes through a 2% agarose gel and stained with ethidium bromide. The gels were examined for evidence of polymorphic patterns. Putative polymorphisms identified by this screen were confirmed by separately digesting 5 l of PCR product from each isolate in the group, in a total volume of 10 l each, and examining the individual digests in adjacent lanes on a 2% agarose gel. To ensure that polymorphisms identified between isolates were not the result of errors introduced during PCR amplification, results were confirmed by a second and independent PCR amplification. DNA sequence analysis. The PCR product from strain 4, amplified from the metalloprotease gene with the first pair of primers shown in Table 2 , was ligated into plasmid pGEM-T (Promega, Madison, Wis.) and transformed into Escherichia coli JM109, as described by the manufacturer. DNA sequence was determined for approximately 150 bp from either end of the cloned PCR product in this plasmid, as described previously (4), with the forward and reverse primers from pUC19.
PFGE. For each S. epidermidis isolate, DNA was isolated in agarose, digested with SmaI, and separated by PFGE as previously described (8) . PFGE profiles were interpreted as described by Tenover et al. (11) .
There were only a very limited number of biotypes (3) among the 33 isolates confirmed to be S. epidermidis by speciation, and results of duplicate testing of biotypes were often not concordant, confirming that biotyping of S. epidermidis has poor discriminatory power for strain identification. Epidemiological information on the S. epidermidis isolates is provided in Table 1 and forms the basis of the expected relationships of the various isolates. Fourteen of the isolates were from patients with prosthetic valve endocarditis treated at the Massachusetts General Hospital (isolates 4, 12, 13, 15, 16, 17, 31, 11, 14, 21, 22, 20, 58, and 61). The first seven of these represent single isolates recovered from blood cultures of different patients without any known epidemiologic connection. Isolates 11 and 14 were recovered from the same patient with prosthetic valve endocarditis over an approximately 1-month interval. Isolates 21, 22, and 20 were similarly recovered from the same patient over an approximately 1-month interval. Isolates 58 and 61 were recovered from the same patient; the second isolate, number 61, was recovered at relapse of infection approximately 6 weeks after the first. Isolates 898A1 through 898A6 were previously reported by Boyce et al. (2) ; the first five of these isolates were part of the identified outbreak and the sixth was a control strain. Isolates 903A1 through 903A25 were previously described by Mickelsen et al. (9) ; isolates 903A1 through 903A18 were part of the reported epidemic and isolates 903A24 and 903A25 were control strains.
Primer pair 1 generated the predicted 981-bp fragment from S. epidermidis isolate number 4 ( Table 2) . To obtain a rough estimate of the amount of divergence at the nucleotide level between two arbitrarily chosen S. epidermidis strains, we determined approximately 150 bp of the nucleotide sequence at either end of this fragment and compared it with the corresponding S. epidermidis sequence deposited in GenBank. The sequence obtained from isolate 4 confirmed that a fragment of the gene encoding the metalloprotease which differed from the sequence deposited in GenBank at 7 of 312 bp, mostly in the third positions of codons (data not shown had been amplified). This represents approximately 2% divergence between clinical isolate 4 and the isolate whose sequence is recorded in the database, suggesting that there is sufficient polymorphism between S. epidermidis strains to pursue the CAPS typing strategy.
When the primer pairs listed in Table 2 were used to amplify fragments of DNA from each of the 33 S. epidermidis strains listed in Table 1 , each pair of primers amplified a single PCR product, and the size of each PCR product was as predicted from the nucleotide sequence (data not shown). We examined for restriction site polymorphisms within these PCR products as described above. We identified a total of seven restriction site polymorphisms in fragments 1, 2, 5, 6, and 8 but none in fragments 3 and 4 (Tables 2 and 3 ). Each fragment-enzyme combination that was polymorphic demonstrated only two alleles, corresponding to the presence or absence of a single restriction site (designated by the numbers 1 and 2, respectively). For some restriction enzymes, additional sites were present within the fragment, but were not polymorphic among the isolates studied. Overall, five distinct combinations of alleles were detected and were designated CAPS types A through E ( Table 4) . Each of the epidemiologically linked sets of isolates (11 and 14; 58 and 61; 20, 21 and 22; 898A1 through 898A5; and 903A1 through 903A18) was grouped together by CAPS. SmaI chromosomal DNA digests from each of the 33 S. epidermidis isolates were resolved by PFGE, and the patterns were analyzed as proposed by Tenover et al. (11) . As shown in Table 5 , there was close correlation between typing by CAPS and by PFGE. Although PFGE typing was more discriminatory (with isolates from the same CAPS group sometimes distributing into more than one PFGE group), no isolates from the same PFGE group were found in more than one CAPS group. In addition to isolates 11 and 14, three other isolates were placed in both CAPS group A and PFGE group I. Although all of these isolates were obtained from patients with prosthetic valve endocarditis at the Massachusetts General Hospital, these additional isolates were not apparently linked epidemiologically to isolates 11 and 14. Although all of the prosthetic valves in these patients were inserted at the Massachusetts General Hospital, the dates of surgery ranged over more than 18 months, arguing against an unrecognized common-source outbreak. In addition, isolates 13 and 17, which were recovered from patients with prosthetic valve endocarditis whose valves were inserted during the same time interval, fell into different CAPS and PFGE groups.
CAPS also successfully differentiated the outbreak from the control strains for isolates 898A1 to A6 and for isolates 903A1 to A25. Again, however, PFGE had better discriminatory power in separating CAPS types D and E into more than one PFGE type each.
In discussing CAPS as a strain-typing system, it is useful to consider several previously described criteria (1) . Although all isolates should be typeable by the CAPS method, two of 35 isolates failed to give reproducible PCR products by a rapid procedure for obtaining DNA. The reason(s) for these failures 4  2  2  1  1  2  1  2  1 1  2  2  1  1  2  1  2  1 2  2  2  1  1  2  1  2  1 remain unclear; we did not attempt to extract purified DNA. For the remaining 33 isolates, the results of CAPS typing were highly reproducible with no detectable variation either in vitro, when the same isolate was analyzed on separate occasions, or in vivo, when analyzing multiple isolates representing a single strain as defined by independent epidemiologic and straintyping studies. This was true not only for sets of 2 and 3 isolates from three individual patients but also for the sets of 5 and 11 isolates representing the two different outbreak strains. PFGE analyses demonstrated minor variations (single genetic differences) among the isolates representing the larger outbreak and for a pair of isolates from a single patient. As previously described, such variations are commonly encountered with PFGE studies of staphylococcal strains (1, 10) . The discriminatory power of this particular CAPS analysis was only modest. CAPS was able to distinguish each of the two outbreak strains from their associated controls but designated both outbreak strains as a single type and all three control isolates as a single albeit different type. In contrast, PFGE and ribotyping (data not shown) resolved the two outbreak strains and the three control isolates into five distinctly different types. Nevertheless, the results obtained from the CAPS analysis and from the limited sequencing we performed support the hypothesis that, at least among S. epidermidis isolates, there is sufficient sequence variation even within coding sequences to permit distinguishing among epidemiologically unrelated isolates.
More extensive sequence data confirming this have been reported for E. coli (3) .
The CAPS procedure represents a straightforward application of three widely disseminated technologies: PCR, restriction endonuclease digestion, and resolution of restriction digests by routine agarose gel electrophoresis. Both the capital cost of the equipment required and the technical expertise involved are modest and potentially available in many clinical microbiology laboratories. Of note, once a protocol is defined, sets of up to 20 isolates can typically be analyzed within 2 days. Since the patterns being observed represent restriction digests of well-defined amplicons, the entire procedure is relatively easy to quality control and the results can be readily interpreted. Even in this preliminary form, CAPS might provide clinically and epidemiologically useful information, since determining that two isolates have different patterns would be very strong evidence that they represent different strains.
Compared with typing systems currently available, CAPS offers several distinct advantages. PFGE, the current procedure of choice for analyzing staphylococci, has greater discriminatory power than the CAPS implementation described here, but it requires specialized equipment and longer procedure time (1) . Although standardized guidelines for the interpretation of PFGE profiles have recently been proposed (11), the process of interpreting and describing CAPS results is intrinsically more objective. Arbitrarily primed PCR, which has been widely applied in recent years, might appear simpler because fewer primers are required and there are no restriction digests. However, arbitrarily primed PCR results can show considerable variation due to technical factors, which limits the discriminatory power of the technique and complicates the interpretation of gel patterns (13) .
In summary, our data suggest that CAPS represents a PCRbased technique for S. epidermidis typing that is highly reproducible, rapid, utilizes widely available technologies, and provides results that are relatively easy to interpret and express. Although this particular implementation demonstrated limited discriminatory power, the approach can be easily enlarged and potentially automated. The data generated by CAPS should be directly applicable to studies of population genetics as well as to clinical and epidemiologic investigations. 
